Delivery Order SPE2DX22D0039-SPE2D826F0DF4
- Not listed
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $16,670.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 4, 2025, with completion scheduled for December 5, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, a major pharmaceutical distributor...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $23,319.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with an ultimate completion date of December 9, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 16, 2025, with a ceiling value of $1,848.96. This firm fixed-price delivery order, which represents a non-competitive, non-set-aside award, is scheduled for completion by December 17, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,296.85 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to the prime contractor for pharmaceutical and medical supply products. The contract is performance-based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,270.16 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 23, 2025, with an ultimate completion date of December 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's existing contract vehicle. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $30,958.38 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order, which does not utilize a set-aside designation, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $66,960 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $6,545.30 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 1, 2025, with an ultimate completion date of December 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value through December 2026. The delivery...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,593.00 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 22, 2025, with completion scheduled for December 23, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $1,620.12 delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 15, 2025, with completion expected by December 16, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract arrangement and represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor for federal medical procurement. The award utilizes no set-aside designation, reflecting...
- SPE2DX22D0039Indefinite Delivery Contract
- SPE2DX22D0039-SPE2D826F0DF4Delivery Order
The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $16,684.20 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on December 29, 2025, with an ultimate completion date of December 30, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal military and veteran healthcare systems. The delivery order falls within AmerisourceBergen's comprehensive pharmaceutical and medical supply portfolio delivered under the DLA Troop Support Medical IDC, which encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor under this vehicle, AmerisourceBergen supplies pharmaceutical products to support Defense Health Agency operations and other federal healthcare systems worldwide. The award demonstrates the company's capability to meet competitive federal procurement requirements and reflects its significant role in supporting the DLA's Pharmaceutical Prime Vendor Global Program, which is structured to make multiple awards across separate regions to multiple contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 12/28/25 |